倒计时5天 2025（第十届）起点锂电行业年会暨锂电金鼎奖颁奖典礼 &起点研究十周年庆典 2025起点用户侧储能及电池技术论坛 活动主题： 新周期 新技术 新生态 活动时间： 2025年12月18-19日 活动地址： 深圳市维纳斯皇家酒店（深圳国际会展中心京基百纳店）三楼维纳斯厅（深圳市宝安区沙井 镇沙井路118号） 主办单位： 起点锂电、起点储能、起点研究院SPIR 赞助及演讲单位： 惠州潼湖生态智慧区管理委员会/逸飞激光/小鲁锂电/派能科技/莫洛奇/融捷能源/远 东电池/诺达智慧/奥鸿智能/中天和/超业精密/北测新能源/蓝京新能源/贤辰智享/东唐智能/达力智能/ 亿鑫丰/爱签/和明机械/金力股份/孚悦科技/乾纳智能装备/多氟多/科迈罗/三合一体/果曼钠电/新能安/ 海辰储能/瑞浦兰钧/鹏辉能源/国轩吉泰美/创明新能源/德赛电池/先导智能/亿纬锂能/移族/新日股份/ 弘正储能/亮见钠电/易事特/清陶云能/信宇人/星恒电源/昆仑化学/星翼能源 /汇创新能源 等 杉杉集团发布公司重组消息以来，吸引了多方投资者入局参与竞争，未来谁将取得杉杉控制权，变得扑朔迷离！ 一时多少豪杰？ 起点锂电经过梳理发现，有以下几家势 ...

Core Insights - The completion of the acquisition of Kanghua Biological by Shanghai Biopharmaceutical M&A Fund through Wankexin Biological was marked by a ceremony in Chengdu on November 27, 2025 [1] Group 1: Company Developments - New Kanghua Biological aims to introduce fresh capital to drive development, indicating a strategic shift following the acquisition [3] - The new chairman of Kanghua Biological, Liu Dawei, emphasized the company's established reputation and the importance of capital and industry integration for future growth [4] - Strategic agreements were signed with several partners and professional institutions to support market layout and channel expansion for New Kanghua Biological [4] Group 2: Industry Context - The president of the China Vaccine Industry Association highlighted the opportunities in China's vaccine industry, noting an improving policy environment that could benefit New Kanghua Biological [3] - The collaboration between Shanghai and Chengdu in the biopharmaceutical sector is expected to enhance research and development, clinical practices, and industrial cooperation [4]

Core Viewpoint - The acquisition of Kanghua Biotech by the Shanghai Biopharmaceutical M&A Fund through Wankexin Biotech marks a significant development in the biopharmaceutical industry, aiming to enhance Kanghua's capabilities and market position in the vaccine sector [1]. Group 1: Acquisition Details - The acquisition was officially completed on November 27, 2025, during the unveiling and ecological cooperation conference held in Chengdu [1]. - The event was attended by various leaders and representatives from the biopharmaceutical industry, indicating strong support and interest in the collaboration [3]. Group 2: Strategic Vision and Goals - Kanghua Biotech's Vice Chairman emphasized the need for fresh blood to drive development, highlighting the importance of the partnership with the M&A fund for future progress [3]. - The President of Shanghai Shiyuan Group expressed hopes that the acquisition would facilitate collaboration between Shanghai and Chengdu in research, clinical trials, and industrialization [7]. Group 3: Industry Context and Opportunities - The President of the China Vaccine Industry Association noted that the vaccine industry in China is facing development opportunities, with an improving policy environment that could benefit Kanghua Biotech [5]. - Kanghua Biotech aims to leverage its existing rabies vaccine foundation to build a comprehensive rabies prevention service system [5]. Group 4: Strategic Partnerships - During the conference, Kanghua Biotech signed strategic agreements with several partners, including Shanghai Pharmaceutical Holdings and eight service providers, to support market expansion and channel development [12][14].

Core Insights - The article celebrates the 10th anniversary of Wens Foodstuff Group's listing, highlighting its journey of integrating traditional industry with capital markets, achieving significant milestones in revenue and product supply [2] - Over the past decade, Wens has maintained a focus on its core philosophy of being industry-based while leveraging capital, resulting in substantial contributions to the agricultural sector and a remarkable growth story [2] Chapter Summaries Chapter 1: Breaking Ground - Wens' journey to listing began with the vision of its founder to create a strong company that could be publicly traded, culminating in its successful listing in 2015 with a market value exceeding 200 billion yuan on the first day [3] - The current chairman emphasized the importance of using industrial strength to support market trust and the need for effective capital tools to build an ecosystem [3] Chapter 2: Rooting Development - The listing brought social oversight, prompting Wens to enhance its governance and operational standards, ensuring compliance with regulatory requirements and modernizing its management [7][8] - The company established a robust governance structure, transitioning from unilateral decision-making to a more systematic approach, which improved management efficiency [8][9] Chapter 3: Riding the Storm - The African swine fever outbreak in 2018 led to significant challenges for the pig farming industry, with Wens facing its first annual loss post-listing [10] - Despite these challenges, Wens demonstrated resilience by focusing on biosecurity measures and strategic adjustments, including halting new pig farm constructions to safeguard cash flow [10][11] - The company successfully raised capital through bond issuances, enhancing its financial stability during downturns [11][14] Chapter 4: Transforming and Growing - Wens has consistently emerged stronger from industry cycles, achieving record sales figures in 2024, including 30.18 million pigs sold and over 1 billion yuan in revenue [18] - The company has invested in digital technologies and innovative breeding practices, establishing itself as a leader in the industry [18][20] - Wens has committed to green development, investing over 6.64 billion yuan in sustainable practices and significantly reducing carbon emissions [22] Chapter 5: A Decade of Growth and Responsibility - Over the past ten years, Wens has seen its revenue grow from 48.24 billion yuan to 104.92 billion yuan, with a compound annual growth rate of 8.1% [28] - The company has distributed over 28.12 billion yuan in dividends, maintaining a high payout ratio even during losses [28] - Wens has positively impacted its partner farmers, generating 86.66 billion yuan in income for them, reflecting its commitment to social responsibility [28] Chapter 6: The Next Chapter - Wens aims to continue its focus on the agricultural sector, aspiring to become a leading provider of meat, egg, and dairy products in China while enhancing consumer engagement [31] - The company emphasizes a long-term vision of sustainable growth and collaboration with partners to ensure mutual success in the agricultural landscape [31]